KADIAN - 16590-885-60 - (MORPHINE SULFATE)

Alphabetical Index


Drug Information of KADIAN

Product NDC: 16590-885
Proprietary Name: KADIAN
Non Proprietary Name: MORPHINE SULFATE
Active Ingredient(s): 200    mg/1 & nbsp;   MORPHINE SULFATE
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of KADIAN

Product NDC: 16590-885
Labeler Name: STAT RX USA LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020616
Marketing Category: NDA
Start Marketing Date: 20090407

Package Information of KADIAN

Package NDC: 16590-885-60
Package Description: 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-885-60)

NDC Information of KADIAN

NDC Code 16590-885-60
Proprietary Name KADIAN
Package Description 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-885-60)
Product NDC 16590-885
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name MORPHINE SULFATE
Dosage Form Name CAPSULE, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20090407
Marketing Category Name NDA
Labeler Name STAT RX USA LLC
Substance Name MORPHINE SULFATE
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]

Complete Information of KADIAN


General Information